Motif Bio plc ADRs
MTFB
MTFB was delisted on the 16th of December, 2019.
5 hedge funds and large institutions have $12M invested in Motif Bio plc ADRs in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$6.34M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$4.93M |
| 3 |
Jane Street
New York
|
+$74.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$13.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$582 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Invesco
Atlanta,
Georgia
| $6.75M | +$6.34M | +1,090,800 | New |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $5.12M | +$4.93M | +847,826 | New |
|
|
3
Jane Street
New York
| $79K | +$74.3K | +12,779 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $14K | +$13.4K | +2,309 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $1K | +$582 | +100 | New |
|
MTFB Hedge Fund Activity: Q4 2016 in Review
5 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc ADRs (MTFB) for Q4 2016, worth a combined $12M.
Buyers outnumbered sellers: 5 funds opened new MTFB positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Invesco, opening a new position worth an estimated $6.34M.
- 5 institutional investors held Motif Bio plc ADRs (MTFB) as of Q4 2016, up from 0 in Q3 2016.
- Funds reported $12M of Motif Bio plc ADRs stock for Q4 2016.
- 5 funds opened new Motif Bio plc ADRs positions in Q4 2016 and 0 closed out, a net change of +5 holders.
- The largest Motif Bio plc ADRs buyer in Q4 2016 was Invesco, an estimated $6.34M added.
Based on aggregated 13F filings for Q4 2016.